Stocktoria

InfuSystem Holdings, Inc INFU

NYSE American · XASE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2006-06-15

InfuSystem Holdings, Inc statistics & valuation

Market cap$199.4M
P / E30.1×
P / S1.4×
P / B3.5×
P / FCF8.4×
Net margin4.6%
FCF margin16.6%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.

P / E vs its own history

InfuSystem Holdings, Inc trades at about 31.5× earnings — below its 10-year norm (10-year range 18.4×–251.7×, median 37.3×).

18.4× 251.7×

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin56.0%52.2%50.2%55.1%57.2%60.3%57.8%58.9%61.0%63.5%
Operating margin8.3%5.1%3.2%1.5%2.8%9.1%4.3%0.6%-5.4%1.4%
Net margin4.6%1.7%0.7%0.0%1.4%17.8%1.7%-1.6%-29.1%-0.3%
FCF margin16.6%14.4%8.1%15.0%16.9%19.7%13.5%16.5%10.7%11.0%
Return on assets6.6%2.3%0.8%0.0%1.5%17.9%1.7%-1.7%-30.1%-0.2%
Return on equity11.6%4.1%1.7%0.0%2.9%42.5%6.1%-5.4%-66.9%-0.4%
Debt / equity0.34×0.41×0.56×0.69×0.69×0.95×1.72×1.65×0.92×0.63×
Current ratio1.801.821.951.711.711.290.881.191.421.26

Source: SEC EDGAR filings · CIK 0001337013 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.